Ginkgo Bioworks Holdings, Inc.
DNA- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001830214
In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $359.2M in total; Viking Global Investors is the only superinvestor holding it.
Holders of 5% or more of DNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ginkgo Bioworks Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Shetty Reshma P. | 13D/A | 9.50%4.72M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Cascade Investment, L.L.C. | 13G/A | 7.50%3.62M shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| BlackRock, Inc. | 13G | 6.50%3.00M shares | New | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| Che Austin | 13G/A | 5.00%2.37M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Ginkgo Bioworks Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 20266:36 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.13 ppfrom 5.13%Below 5% | Mar 13, 2026 | SEC |
| Feb 5, 202610:10 AM ET | Baillie Gifford & Co | 13G/A | 4.90%2.39M shares | –Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:16 PM ET | Cascade Investment, L.L.C.and 1 other | 13G/A | 7.50%3.62M shares | – | Sep 30, 2025 | SEC |
| Jul 29, 20251:34 PM ET | Vanguard Group Inc | 13G | 5.13%2.38M shares | +0.68 ppfrom 4.45% | Jun 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G | 6.50%3.00M shares | New | Jun 30, 2025 | SEC |
| Feb 14, 20254:04 PM ET | Che Austin | 13G/A | 5.00%2.37M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:03 PM ET | Shetty Reshma P.and 1 other | 13D/A | 9.50%4.72M shares | – | Feb 14, 2025 | SEC |
| Jan 30, 20259:58 PM ET | Vanguard Group Inc | 13G/A | 4.45%2.01M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 10, 20259:25 PM ET | ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ginkgo Bioworks Holdings, Inc. shares.
No Form 144 notices for Ginkgo Bioworks Holdings, Inc. are on file.